BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22158627)

  • 1. Genomic promoter occupancy of runt-related transcription factor RUNX2 in Osteosarcoma cells identifies genes involved in cell adhesion and motility.
    van der Deen M; Akech J; Lapointe D; Gupta S; Young DW; Montecino MA; Galindo M; Lian JB; Stein JL; Stein GS; van Wijnen AJ
    J Biol Chem; 2012 Feb; 287(7):4503-17. PubMed ID: 22158627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt/β-Catenin Signaling Activates Expression of the Bone-Related Transcription Factor RUNX2 in Select Human Osteosarcoma Cell Types.
    Vega OA; Lucero CMJ; Araya HF; Jerez S; Tapia JC; Antonelli M; Salazar-Onfray F; Las Heras F; Thaler R; Riester SM; Stein GS; van Wijnen AJ; Galindo MA
    J Cell Biochem; 2017 Nov; 118(11):3662-3674. PubMed ID: 28370561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma.
    van der Deen M; Taipaleenmäki H; Zhang Y; Teplyuk NM; Gupta A; Cinghu S; Shogren K; Maran A; Yaszemski MJ; Ling L; Cool SM; Leong DT; Dierkes C; Zustin J; Salto-Tellez M; Ito Y; Bae SC; Zielenska M; Squire JA; Lian JB; Stein JL; Zambetti GP; Jones SN; Galindo M; Hesse E; Stein GS; van Wijnen AJ
    J Biol Chem; 2013 Jul; 288(29):21307-21319. PubMed ID: 23720736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cancer-related transcription factor RUNX2 modulates expression and secretion of the matricellular protein osteopontin in osteosarcoma cells to promote adhesion to endothelial pulmonary cells and lung metastasis.
    Villanueva F; Araya H; Briceño P; Varela N; Stevenson A; Jerez S; Tempio F; Chnaiderman J; Perez C; Villarroel M; Concha E; Khani F; Thaler R; Salazar-Onfray F; Stein GS; van Wijnen AJ; Galindo M
    J Cell Physiol; 2019 Aug; 234(8):13659-13679. PubMed ID: 30637720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-205 acts as a tumor suppressor in osteosarcoma via targeting RUNX2.
    Zhang C; Long F; Wan J; Hu Y; He H
    Oncol Rep; 2016 Jun; 35(6):3275-84. PubMed ID: 27035764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RUNX2 controls human IPO8 basal transcription in Saos-2 cells.
    Xiong J; Hu Z; Wang T; Xu X; Liu J; Wu P; Che X; Li W
    Mol Med Rep; 2016 Aug; 14(2):1418-24. PubMed ID: 27277970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines.
    Lucero CM; Vega OA; Osorio MM; Tapia JC; Antonelli M; Stein GS; van Wijnen AJ; Galindo MA
    J Cell Physiol; 2013 Apr; 228(4):714-23. PubMed ID: 22949168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.
    Jia F; Zhang Z; Zhang X
    J Cell Biochem; 2019 Apr; 120(4):6420-6430. PubMed ID: 30484892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of the WNT5A Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2.
    Vaidya H; Rumph C; Katula KS
    PLoS One; 2016; 11(3):e0151392. PubMed ID: 26978652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin.
    Mendoza-Villanueva D; Zeef L; Shore P
    Breast Cancer Res; 2011 Oct; 13(5):R106. PubMed ID: 22032690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion.
    Pratap J; Javed A; Languino LR; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    Mol Cell Biol; 2005 Oct; 25(19):8581-91. PubMed ID: 16166639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RUNX2 expression in developing human bones and various bone tumors.
    Sugawara M; Kato N; Tsuchiya T; Motoyama T
    Pathol Int; 2011 Oct; 61(10):565-71. PubMed ID: 21951664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-activator activator (CoAA) prevents the transcriptional activity of Runt domain transcription factors.
    Li X; Hoeppner LH; Jensen ED; Gopalakrishnan R; Westendorf JJ
    J Cell Biochem; 2009 Oct; 108(2):378-87. PubMed ID: 19585539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of WWOX, RUNX2 and VEGFA protein expression in human osteosarcoma.
    Yang J; Zhao L; Tian W; Liao Z; Zheng H; Wang G; Chen K
    BMC Med Genomics; 2013 Dec; 6():56. PubMed ID: 24330824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired cell cycle regulation of the osteoblast-related heterodimeric transcription factor Runx2-Cbfbeta in osteosarcoma cells.
    San Martin IA; Varela N; Gaete M; Villegas K; Osorio M; Tapia JC; Antonelli M; Mancilla EE; Pereira BP; Nathan SS; Lian JB; Stein JL; Stein GS; van Wijnen AJ; Galindo M
    J Cell Physiol; 2009 Dec; 221(3):560-71. PubMed ID: 19739101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservation and expression of an alternative 3' exon of Runx2 encoding a novel proline-rich C-terminal domain.
    Terry A; Kilbey A; Vaillant F; Stewart M; Jenkins A; Cameron E; Neil JC
    Gene; 2004 Jul; 336(1):115-25. PubMed ID: 15225881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the GATA factor TRPS1 as a repressor of the osteocalcin promoter.
    Piscopo DM; Johansen EB; Derynck R
    J Biol Chem; 2009 Nov; 284(46):31690-703. PubMed ID: 19759027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated expression of Runx2 as a key parameter in the etiology of osteosarcoma.
    Nathan SS; Pereira BP; Zhou YF; Gupta A; Dombrowski C; Soong R; Pho RW; Stein GS; Salto-Tellez M; Cool SM; van Wijnen AJ
    Mol Biol Rep; 2009 Jan; 36(1):153-8. PubMed ID: 18931939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of osteoblast gene expression profiles and Runx2 genomic occupancy of mouse and human osteoblasts in vitro.
    Tarkkonen K; Hieta R; Kytölä V; Nykter M; Kiviranta R
    Gene; 2017 Aug; 626():119-131. PubMed ID: 28502869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility.
    Leong DT; Lim J; Goh X; Pratap J; Pereira BP; Kwok HS; Nathan SS; Dobson JR; Lian JB; Ito Y; Voorhoeve PM; Stein GS; Salto-Tellez M; Cool SM; van Wijnen AJ
    Breast Cancer Res; 2010; 12(5):R89. PubMed ID: 21029421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.